BACKGROUND: Full-thickness chondral defects and early osteoarthritis continue to present major challenges for the patient and the orthopaedic surgeon as a result of the limited healing potential of articular cartilage. The use of bioactive growth factors is under consideration as a potential therapy to enhance healing of chondral injuries and modify the arthritic disease process. QUESTIONS/PURPOSES: We reviewed the role of growth factors in articular cartilage repair and identified specific growth factors and combinations of growth factors that have the capacity to improve cartilage regeneration. Additionally, we discuss the potential use of platelet-rich plasma, autologous-conditioned serum, and bone marrow concentrate preparations as methods of combined growth factor delivery. METHODS: A PubMed search was performed using key words cartilage or chondrocyte alone and in combination with growth factor. The search was open for original manuscripts and review papers and open for all dates. From these searches we selected manuscripts investigating the effects of growth factors on extracellular matrix synthesis and excluded those investigating molecular mechanisms of action. RESULTS: By modulating the local microenvironment, the anabolic and anticatabolic effects of a variety of growth factors have demonstrated potential in both in vitro and animal studies of cartilage injury and repair. Members of the transforming growth factor-β superfamily, fibroblast growth factor family, insulin-like growth factor-I, and platelet-derived growth factor have all been investigated as possible treatment augments in the management of chondral injuries and early arthritis. CONCLUSIONS: The application of growth factors in the treatment of local cartilage defects as well as osteoarthritis appears promising; however, further research is needed at both the basic science and clinical levels before routine application.
BACKGROUND: Full-thickness chondral defects and early osteoarthritis continue to present major challenges for the patient and the orthopaedic surgeon as a result of the limited healing potential of articular cartilage. The use of bioactive growth factors is under consideration as a potential therapy to enhance healing of chondral injuries and modify the arthritic disease process. QUESTIONS/PURPOSES: We reviewed the role of growth factors in articular cartilage repair and identified specific growth factors and combinations of growth factors that have the capacity to improve cartilage regeneration. Additionally, we discuss the potential use of platelet-rich plasma, autologous-conditioned serum, and bone marrow concentrate preparations as methods of combined growth factor delivery. METHODS: A PubMed search was performed using key words cartilage or chondrocyte alone and in combination with growth factor. The search was open for original manuscripts and review papers and open for all dates. From these searches we selected manuscripts investigating the effects of growth factors on extracellular matrix synthesis and excluded those investigating molecular mechanisms of action. RESULTS: By modulating the local microenvironment, the anabolic and anticatabolic effects of a variety of growth factors have demonstrated potential in both in vitro and animal studies of cartilage injury and repair. Members of the transforming growth factor-β superfamily, fibroblast growth factor family, insulin-like growth factor-I, and platelet-derived growth factor have all been investigated as possible treatment augments in the management of chondral injuries and early arthritis. CONCLUSIONS: The application of growth factors in the treatment of local cartilage defects as well as osteoarthritis appears promising; however, further research is needed at both the basic science and clinical levels before routine application.
Authors: Allan Mishra; Padmaja Tummala; Aaron King; Byung Lee; Mark Kraus; Victor Tse; Christopher R Jacobs Journal: Tissue Eng Part C Methods Date: 2009-09 Impact factor: 3.056
Authors: S S Smyth; R P McEver; A S Weyrich; C N Morrell; M R Hoffman; G M Arepally; P A French; H L Dauerman; R C Becker Journal: J Thromb Haemost Date: 2009-08-19 Impact factor: 5.824
Authors: Michael P Hall; Phillip A Band; Robert J Meislin; Laith M Jazrawi; Dennis A Cardone Journal: J Am Acad Orthop Surg Date: 2009-10 Impact factor: 3.020
Authors: Bojiang Shen; Aiqun Wei; Shane Whittaker; Lisa A Williams; Helen Tao; David D F Ma; Ashish D Diwan Journal: J Cell Biochem Date: 2010-02-01 Impact factor: 4.429
Authors: Andrew S Lee; Michael B Ellman; Dongyao Yan; Jeffrey S Kroin; Brian J Cole; Andre J van Wijnen; Hee-Jeong Im Journal: Gene Date: 2013-07-02 Impact factor: 3.688
Authors: Biao Han; Qing Li; Chao Wang; Pavan Patel; Sheila M Adams; Basak Doyran; Hadi T Nia; Ramin Oftadeh; Siyuan Zhou; Christopher Y Li; X Sherry Liu; X Lucas Lu; Motomi Enomoto-Iwamoto; Ling Qin; Robert L Mauck; Renato V Iozzo; David E Birk; Lin Han Journal: ACS Nano Date: 2019-10-01 Impact factor: 15.881
Authors: Ron Gilat; Eric D Haunschild; Derrick M Knapik; Aghogho Evuarherhe; Kevin C Parvaresh; Brian J Cole Journal: Int Orthop Date: 2020-09-15 Impact factor: 3.075
Authors: Troy D Bornes; Nadr M Jomha; Aillette Mulet-Sierra; Adetola B Adesida Journal: Tissue Eng Part C Methods Date: 2016-01-18 Impact factor: 3.056